Always amazing to me whenever good news hits the tape for $SMMT, all the science/oncology/arm chair drug development “experts”on here trash the data…never once have seen the big accounts acknowledge good news. I guess they know more than everybody else!
@ThruTheBridle Sucks in person. On tv, if they did it like the aussie’s with the a/b/c tracks which have one continuous and cohesive betting program, it would be 100x better…
@DamaskCapital@ACapitalLP Totally agree! I think both sides can be dangerous with $SMMT - there is a lot of confident people who think they know the science better than most on both the bear and bull side of the argument.
@DamaskCapital@ACapitalLP Competitive yes, but you can’t say thats unique to $SMMT. Wouldn’t every China oncology collab being done by the largest pharma’s in the world be held to the same cautionary statement?
@TimCarmichael3 100% agree $SMMT has been weak the past year - off 42% when $XBI is up 87%. Difference now is $AZN ain’t getting Summit anywhere near the $15B that was rumored (if they wanted).
What made the latest Akeso win sweet is Imfinzi is almost 25% of $AZN oncology revenue….
You can always tell an overly emotional $SMMT bear or an intellectual who thinks they know the science better than everyone else - they can’t help but use derogatory language describing Ivo…even the most eloquent “analysis” from them should be taken with a grain of salt…
$SMMT a lot of talk about OS recently….in case anyone wanted some context, only about one-third of all oncology approvals over the past two decades have had OS stat sig - what $SMMT has done is not remotely unusual or something that should be concerning to anyone…
It would be great if $SMMT would make a statement about the false and at best, misleading articles that all the usual suspects are releasing the past couple of days pushing prices lower…Maybe the @SECGov would be interested as well with some of those well timed puts?? #IYKYK
$SMMT I promise you, no bad information is coming out. Either a degen trader or someone trying to accumulate went long those puts - no one is stupid enough to trade inside info 8 days to expiration…just playing games with the float
Grateful to @MarleyKayden and the entire @SchwabNetwork team for having me on this afternoon.
We unpacked the biggest questions investors are wrestling with right now in the wake of earnings season and the latest Fed meeting — most notably: when does all this AI spending start showing up in meaningful returns?
I also shared why I’m constructive on three areas that still look mispriced: U.S. small caps, commodities, and emerging markets. Attractive valuations, inflation protection, and leverage to the global AI supply chain are a powerful combination, even with geopolitical noise still elevated.
Appreciate the thoughtful conversation, Marley. Always a pleasure.
#SchwabNetwork #Investing #AI #SmallCaps #EmergingMarkets
Watch the full clip here:
https://t.co/T50uHHE5gC
$SMMT incredible how they continuously move the goal posts…literally continuously great news. They are running out of hits - now it’s the “going concern” language…Lol anyone with half a brain knows they have had that language forever in their 10q’s…
@flippyfloppy52 That is how I see it. I am a firm $SMMT bull so maybe I am a little biased (I try not to be) but the potential $AZN deal was in July of last year. An additional year of trials derisks that prior deal and because of that, the multiple is even higher than the prior $15b one